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- The in vitro mutagenicity and genotoxicity of Cylindrospermopsin (CYN) have been evaluated 
- The Ames test, micronucleus (MN), mouse lymphoma and standard and modified comet 
assays were performed to evaluate CYN  
- Only the MN assay with metabolic fraction S9 provided positive results suggesting pro-
genotoxic potential for CYN 





 Cylindrospermopsin (CYN) is a cyanobacterial toxin considered as an emerging threat 
worldwide due to the progressive distribution of its main producer, Cylindrospermopsis 
raciborskii (Kinnear, 2010; Poniedzialek et al., 2012). CYN molecule consists of a tricyclic 
guanidine group combined with a hidroximethyl uracil (Ohtani et al., 1992). Its zwitterionic 
nature makes it highly water soluble and stable at extreme temperatures and pH (Falconer et 
al., 2006). Humans are more susceptible to the exposure to CYN in comparison to other 
cyanotoxins because up to 90% of total CYN is found outside the cyanobacterial cells (Rücker 
et al., 2007). In this sense, CYN has been documented as being involved in at least two 
epidemical cases of human poisoning (Carmichael et al., 2001; Griffiths and Saker, 2003) and it 
has been identified in some water reservoirs supplying drinking water (Bittencourt-Oliveira et 
al., 2014; Lei et al., 2014). Moreover, human exposure to CYN is possible through other 
different pathways such as bathing, recreational water activities, and, mainly, by the 
consumption of contaminated food (fish, mollusks, vegetables, etc.) (Gutiérrez-Praena et al., 
2013). In fact, the bioaccumulation of CYN on fish (up to 2.7 ng/g, Messineo et al., 2010), 
crayfish (up to 4.3 mg/g, Saker and Eaglesham, 1999), mussels (up to 2.52 mg/g, Saker et al., 
2004), lettuce (up to 8.029 µg/kg, Cordeiro-Araújo et al., 2017) etc. has been reported. In this 
regard, the European Food Safety Authority (EFSA) has recommended to collect more data 
about the toxicological profile of cyanotoxins, including CYN (Testai et al., 2016), and Humpage 
and Falconer (2003) proposed a tolerable daily intake of 0.03 mg CYN/kg of body weight. 
 
The main target of CYN activity is the liver (Bernard et al., 2003; Zegura et al., 2011a). 
However, it has been also characterized as cytotoxic due to its negative effects on different 
organs (Runnegar et al., 1994; Terao et al., 1994; Falconer and Humpage, 2006; Guzmán-
Guillén et al., 2013). One of CYN best-known modes of action is the irreversible inhibition of 
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protein synthesis (Terao et al., 1994; Runnegar et al., 1995; Froscio et al., 2003;) that leads to 
cytotoxic effects in a variety of cell cultures (hepatocellular, gastrointestinal tract and kidney 
cell lines) (Humpage et al., 2005; Froscio et al., 2009; Gutiérrez-Praena et al., 2012a). 
Moreover, some authors suggest that CYN cytotoxicity is also dependent on a cytochrome p-
450 metabolism (Runnegar et al., 1995; Froscio et al., 2003) and the activation of CYN seems to 
enhance even more its toxicity (Norris et al., 2002; Humpage et al., 2005; Straser et al. 2011, 
2013a). It has been shown that CYN induces oxidative stress mediated by reactive oxygen 
species (ROS) in a variety of cell types including mouse hepatocytes (Humpage et al., 2005; 
López-Alonso et al., 2013); fish leucocytes (Sieroskawska and Rymuszka, 2013), fish 
hepatocytes (Liebel et al., 2011) and cell lines from different origin such as fish liver (PLHC-1) 
(Gutierrez-Praena et al., 2011a); human colon (Caco-2) (Gutierrez-Praena et al., 2012a), 
umbilical vein endothelium (HUVEC) (Gutierrez-Praena et al., 2012b) and human hepatoma 
(Hep-G2) (Straser et al., 2013b). 
On the other hand, different authors considered CYN a genotoxic compound due to its 
effects on DNA (Zegura et al., 2011a; Moreira et al., 2012). Also, some structural properties, 
such as the presence of uracil (Shen et al., 2002) or potentially reactive guanidine and sulfate 
groups (Bain et al., 2007) have led researchers to suggest a possible interaction of CYN with 
nucleic acids. Two mechanisms have been suggested for its genotoxic activity: 1) loss of 
kinetochore/spindle functions; 2) induction of DNA strand breaks (SBs) at DNA level 
(Sieroslawska, 2010). However, these mechanisms potentially involved in its genotoxicity are 
still under investigation.  
In the scientific literature there are different reports dealing with the in vitro 
mutagenic/genotoxic effects of CYN using different assays (for a review see Pichardo et al., 
2017). Thus, with respect to the Micronucleus (MN) assay, one of the preferred methods for 
assessing chromosome damage (EFSA, 2011), positive results have been obtained in different 
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experimental models. For example, Humpage et al. (2000) observed that CYN (6 and 10 µg/mL) 
increased the incidence of MN in the WIL2-NS lymphoblastic cell line after 48h exposure. 
Similar results were obtained by Straser et al. (2011) in Hep-G2 cells exposed to 0.05 and 0.5 
µg/mL CYN and in peripheral blood lymphocytes (HPBLs) exposed to 0.1 and 0.5 µg/mL CYN as 
shown by Zegura et al. (2011b). In the common carp (Cyprinus carpio L.) leucocyte cell line 0.1 
and 0.5 µg/mL CYN did not show genotoxic effects by the MN assay, but at 1 µg/mL, the 
frequency of MN was significantly higher (Sieroslawska and Rymuszka, 2015). 
According to the studies performed with the comet assay, no DNA damage was 
detected on chinese hamster ovary (CHO-K1) cells after 24 h of treatment with CYN 
concentrations of 0.5 and 1 µg/mL (Fessard and Bernard, 2003) and on fish hepatocytes 
exposed to 0.1-10 µg/mL for 72h (Liebel et al., 2011). However, significant increases of DNA 
SBs were observed in mouse hepatocytes (0.05-0.5 µg/mL) after 18h exposure (Humpage et 
al., 2005), in HPBLs (0.05-0.5 µg/mL) after 4 h (Zegura et al., 2011b) as well as in Hep-G2 cells 
(0.01-0.5 µg/mL) after 12, 24 and 72 h (Straser et al., 2011; Straser et al., 2013b,c). Taking into 
account all these reports, it seems that the concentrations of CYN employed, the experimental 
model, and the type of assay used have a role on the results obtained. Moreover, there are 
additional data gaps regarding the genotoxic potential of CYN. Thus, although it is well known 
that CYN induces oxidative stress it has been not yet elucidated whether this mechanism 
contributes to CYN genotoxicity.  
Studies concerning the influence of CYN on oxidative DNA damage in vitro are very 
scarce. Humpage et al. (2005) and Straser et al. (2013b) concluded that ROS is not a mediator 
of CYN genotoxicity. However, 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-OHdG), a DNA 
oxidation product, was detected in a fish leucocyte cell line after 24 h treatment with CYN 
(Sieroslawska and Rymuszka, 2015). In vivo, DNA oxidation was also detected in tilapia sub-
chronically exposed to environmental relevant concentrations (Guzmán-Guillén et al., 2013). 
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Another controversial point not yet fully elucidated is whether CYN is a genotoxic or a pro-
genotoxic compound due to CYP-mediated metabolites (Zegura et al., 2011a; Straser et al., 
2013a).  
All these contradictory results and uncertainties increase the concerns about CYN 
genotoxicity and make necessary to elucidate its genotoxic potential. In this sense, the 
scientific opinion of EFSA on genotoxicity testing strategies applicable to food and feed safety 
assessment recommends a step-wise approach beginning with a basic battery of in vitro tests, 
comprising 1) a bacterial reverse mutation test (OECD 471), which detects gene mutations and 
2) an in vitro mammalian cell micronucleus test (OECD 487), that covers both structural and 
numerical chromosome aberrations (EFSA, 2011). Regarding to the Ames test, there is only 
one report which evaluated the capacity of CYN as mutagenic agent, showing negative results 
(Sieroslawska, 2013) whereas the MN assay has shown positive results (Bazin et al., 2010; 
Straser et al., 2011; Hercog et al., 2017). 
Taking into account these facts, the aim of this study was to investigate the potential 
mutagenicity and genotoxicity of CYN using a battery of different in vitro assays including: the 
bacterial reverse-mutation assay in Salmonella typhimurium (Ames test, OECD 471), the MN 
test (OECD 487), the standard comet assay on Caco-2 cells and the mouse lymphoma 
thymidine-kinase assay (MLA) on L5178YTk+/− cells, this one applied for the first time to study 
CYN genotoxicity. Moreover, to investigate the involvement of oxidative stress on CYN induced 
DNA damage, an enzyme-modified version of the comet assay was performed. In addition, the 
role of metabolism in CYN genotoxicity was studied by using the S9 fraction as metabolic 
activation system in the Ames, MN and mouse lymphoma assays in order to establish if CYN is 





2. Materials and Methods 
2.1. Supplies and chemicals 
Cylindrospermopsin standard (purity 95%) was supplied by Alexis Corporation (Lausen, 
Switzerland). All assay chemicals were purchased from Sigma–Aldrich (Madrid, Spain), Gibco 
(Biomol, Sevilla, Spain), Moltox (Trinova, Biochem, Germany) and C-Viral S.L. (Sevilla, Spain).  
 
2.2. Cells and culture conditions 
For the Ames test, five Salmonella typhimurium histidine-auxotrophic strains TA97A, 
TA98, TA100, TA102 and TA104 were used. For the MN and MLA tests, L5178Y Tk+/− mouse 
lymphoma cells were originally provided by Dr. Olivier Gillardeux (Safoni-Synthélabo, Paris, 
France). Caco-2 cells, used for standard and enzyme-modified comet assays are derived from a 
human colon carcinoma (ATCC© HTB-37). L5178YTk+/- cells and Caco-2 cell line were cultured 
and maintained according to Mellado-García et al. (2017).  
 
2.3. Test solutions 
A stock solution of CYN (1000 µg/mL) was prepared in milliQ sterile water and 
maintained at less than 4°C. The exposure concentration solutions were made by dilution in 
sterile MilliQ water (Ames test), RPMI 1640 medium (MN and MLA assays) or MEM medium 
(standard and modified-comet assays).  
 
2.4. Ames test 
The mutagenicity test was performed following the principles of OECD guideline 471 
(1997) with the modifications described in Mellado-Garcia et al. (2015), as follows. Briefly, 
cultures of five Salmonella typhimurium histidine-auxotrophic strains (TA97A, TA98, TA100, 
TA102 and TA104) were prepared from their main strain plates and used in their late 
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exponential growth phase. CYN mutagenic activity was assessed in three independent 
experiments using three technical replicates per concentration and per experiment, and in the 
absence and presence of S9 fraction as metabolic activation system from rat livers (S9 fraction 
induced by Aroclor-1254). The S9 fraction is an exogenous metabolising system that should be 
used when employing cells with inadequate endogenous metabolic capacity (OECD guideline 
487). Each experiment included five increasing concentrations of CYN (0.625-10 µg/mL) 
selected according to Sieroslawska (2013). Higher CYN concentrations were not tested as they 
were not considered relevant. Also, a negative control (distilled sterile water) and a positive 
control (depending of the strains and presence or absence of S9 fraction) were included. 
Without S9 fraction for TA 97A/TA98/TA102/TA104 positive control was 2-nitrofluorene (2-NF) 
(0.1 µg/plate), and for TA100, sodium azide (NaN3) (1 µg/plate). Positive control for all strains 
with S9 fraction was 2-aminofluorene (2-AF) (20 µg/plate). Results are expressed as revertant 
colonies and mutagenicity indexes (MI). The MI were calculated as the mean of revertant 
colonies for each concentration and strain divided by the mean of revertant colonies of the 
negative control (Mahon et al., 1989).  
 
2.5. Micronucleus test 
This assay was performed according to the OECD guideline 487 (2016) with the 
modifications described by Maisanaba et al. (2015). L5178YTk+/- cells were seeded at a 
concentration of 2.0×105 cell/mL and treated with five different concentrations of CYN (0-1.35 
µg/mL in the absence of S9 fraction for 24h, and 0-2 µg/mL in the presence of S9 fraction for 
4h). These concentrations were selected based on the mean effective concentrations (EC50) 
obtained in a preliminary cytotoxicity test according to OECD 487 (2016) procedure. RPMI 
medium was used as a negative control, and 0.0625 µg/mL mitomycin (in absence of S9 
fraction) or 8 µg/mL cyclophosphamide (in presence of S9 fraction) were used as positive 
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controls. After specific times of exposure (4 or 24h), cells were exposed to cythochalasin B (6 
µg/mL) for 20 h. Then, cultures were centrifuged and the pellet was subjected to a hypotonic 
treatment with KCl. Afterwards the cells were again centrifuged and fixed. The resultant 
pellets were resuspended, dropped on microscope slides and stained with giemsa 10%. 
Micronuclei frequencies were scored in at least 2000 binucleated cells per concentration. The 
frequency of binucleated cells with micronuclei (BNMN) and the cytokinesis-block proliferation 
index (CBPI) were analyzed according to the recommendations of OECD 487 (2016).  
 
2.6. Mouse lymphoma thymidine-kinase assay (MLA) 
The MLA was performed according to the recommendations of OECD guideline 490 
(2016) and Maisanaba et al. (2015). The experiment comprised a negative control (fresh 
medium), a positive control (methylmethanesulfonate, MMS 10 µg/mL without S9 fraction and 
cyclophosphamide, CP 3 µg/mL with S9 fraction), and six concentrations of CYN in the range 0-
0.675 µg/mL (for 4 and 24h-assays). This range is based on a preliminary toxicity test 
conducted to determine the cytotoxicity of CYN by the relative total growth (RTG) after a 
treatment for 4h with and without S9 fraction and 24 h without S9 fraction. RTG values were 
used to decide on the acceptability of the toxicity at each concentration level, being the 
highest concentration selected for the mutagenic assay higher than 10-20% of RTG based on 
the recommendations of the ICH Expert Working Group (2008) and the OECD guideline. To 
evaluate the viability and mutagenic potential, cells were seeded at a density of 104 cells/mL in 
96-well plates (two replicates per experimental group in each case) and, specifically for the 
mutation analysis, the replicates were also exposed to trifluorothymidine (TFT) at a final 
concentration of 4 µg/mL. After incubation for 12 days at 37 ºC and 5% CO2 viable colonies and 
TFT mutation colonies were counted. In order to assist the scoring of mutant colonies, thiazolyl 
blue tetrazolium (MTT) (2.5 mg/mL) was added to each well and the plates were incubated for 
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4 h before counting. Colony size was estimated in a similar manner to that described by 
Honma et al. (1999); small (less than 1/3 of well diameter) or large (higher than 1/3 of well 
diameter). The induced mutant frequency (IMF) was determined according to the formula IMF 
= MF-SMF, where MF is the test culture mutant frequency and SMF is the spontaneous mutant 
frequency. Positive responses are determined as those that for any treatment meet or exceed 
the global evaluation factor (GEF, 126 x 10-6 for the microwell assay) and also when a positive 
trend is obtained. 
 
2.7. Standard and enzyme-modified comet assay 
The standard comet assay (single cell gel electrophoresis) is the most common method 
for measuring DNA damage in eukaryotic cells (Azqueta and Collins, 2013). Moreover, it has 
been modified to detect oxidized bases, by using the enzymes Endonuclease III (EndoIII), which 
recognizes damaged pyrimidines from double-stranded DNA, and Formamidopyrimidine DNA 
glycosylase (FPG), which detect oxidized purines including 8-oxo-guanine, generating 
apurinic/apyrimidinic-sites (AP-sites).  
The genotoxicity of CYN was evaluated using the standard and modified comet assays, 
as previously described by Collins and Azqueta (2012) and Llana-Ruiz-Cabello et al. (2014). 
Caco-2 cells were plated at density of 3.5× 105 cells/mL into 24-well tissue culture plates and 
exposed for 24h or 48h to 0, 0.625, 1.25 and 2.5 µg/mL CYN. These concentrations were 
selected according to a cytotoxicity study previously performed by Gutierrez-Praena et al. 
(2012a). The most sensitive endpoint observed was the tetrazolium salt reduction (MTS); 
therefore, the EC50 value obtained for this endpoint at 24 h, 2.5 mg/mL CYN, was chosen as the 
higher exposure concentration, along with the fractions EC50/2 and EC50/4. After the 
exposure, Caco-2 cells were washed, trypsinized and resuspended in phosphate buffer saline 
(PBS) at 2.5 x 105 cell/mL. Briefly, the cell suspensions were mixed with pre-warmed (37ºC) 1% 
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(w/v) low-melting-point agarose in PBS, and immediately twelve aliquots of each cell 
suspension were placed on agarose precoated glass slides (one sample from each 
concentration was analyzed on each slide). Then, the slides were incubated in ice-cold lysis 
solution (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris, 1% Triton X-100, pH 10) at 4°C for at least 1 h. 
Afterwards, they were washed with enzyme buffer (buffer F) and two gels in each slide were 
exposed to lysis solution, enzyme buffer alone, buffer F containing FPG and enzyme buffer 
containing Endo III for up to 30 min in a metal-box at 37ºC. Finally, denaturing, 
electrophoresis, neutralizing, fixation, dying and quantification of the nuclei were carried out 
according to Mellado-García et al. (2016). The standard and modified comet assays were 
carried out three times by time assayed. 
A negative control (medium without foetal bovine serum) and positive controls were 
included to monitor the assays. Cells were treated with 100 µM of H202 as positive control for 
the standard comet assay (DNA SBs) and Endo III-sensitive sites. The positive control for FPG-
sensitive sites was 2 µM of Ro 19-8022 photosensitiser (Hoffman-La Roche, Switzerland) 
combined with light irradiation (1.5 min).  
The results were expressed as mean % DNA in tail or tail intensity, which corresponds 
to the intensity of the comet tail relative to the total intensity (tail plus head) and reflects the 
amount of DNA breakage (Kumaravel et al., 2009). To calculate the net FPG or Endo III-
sensitive sites, the median % DNA in tail in the slide treated with buffer F was subtracted from 
the % DNA in tail in slide treated with enzyme.   
 
2.8. Statistical analysis 
Statistical analysis was performed using the analysis of variance (ANOVA) followed by 
Dunnett’s multiple comparison tests. All analyses were performed using Graph-Pad InStat 
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software (Graph-PadSoftware Inc., La Jolla, USA) and IBM SPSS Statistics (Madrid, Spain). 
Differences were considered significant at *p<0.05, **p<0.01 and ***p<0.001, respectively. 
 
3. Results 
3.1 Ames test 
 The results obtained after CYN exposure did not indicate significant differences in 
TA97A, TA98 and TA100 bacterial strains under lab conditions tested (Table 1). In the case of 
TA102 bacterial strain exposed to pure CYN it showed significant differences in absence of 
metabolic fraction (1.25-10 μg/mL) and only at 5 μg/mL in presence of S9 fraction. For TA104, 
statistical differences were only observed at 0.625 µg/mL (in absence and/or presence of the 
external metabolic activation) and at 10 μg/mL (in absence of S9 fraction). However, it has to 
be pointed out that the statistical significance is not the only determining factor for a positive 
result (OCDE 471). The results are considered positive (mutagenic) when there is at least a 2-
fold increase over the control (MI higher than 2) in at least one bacterial strain without or with 
metabolic activation (Mortelmans and Zeiger, 2000). In this case, for all strains the MI were 
less than  2. Consequently, the results proved that CYN was not mutagenic under the 
conditions tested. No signs of precipitation and/or toxicity were observed under the conditions 
studied. Positive controls produced statistically significant increases in the number of revertant 
colonies (p<0.01), as well as the MI was higher than 2, confirming the sensitivity of the test 
system and the activity of the S9 fraction. 
 
3.2 Micronucleus test 
CYN induced a significant increase in the frequency of BNMN in presence of S9 fraction 
at a concentration range between 0.25-2.0 µg/mL (p<0.05; p<0.01) compared to the control 
group (Table 2). However, no significant variations in BNMN % were observed at the lowest 
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concentration tested (0.13 µg CYN/mL) nor in absence of the metabolic fraction (in the range 
0.08-1.35 µg CYN/mL) compared to their respective control groups. Regarding to the CBPI, no 
significant variations were observed in presence nor absence of S9 fraction at any 
concentration tested in comparison to the control group. Moreover, positive controls induced 
a significant increase (p<0.05; p<0.001) in the frequency of MN in presence and absence of S9 
fraction.  
 
3.3 Mouse lymphoma thymidine-kinase assay (MLA) 
The mutagenicity results obtained in the MLA after exposure of L5178Y Tk+/− cells with 
CYN for 4 (with and without S9 fraction) and 24h are shown in Table 3. CYN did not induce a 
mutagenic response at any concentration tested after both times of exposure. Moreover, the 
use of S9 fraction did not influence the results. Positive controls (10 µg/mL MMS without S9 
fraction and 3 µg/mL CP with S9 fraction) were run in parallel, showing significantly increased 
mutant frequencies. Both, negative and positive controls fulfil the acceptance criteria of the 
OECD 490 guideline. Also, a good concordance was observed between the two conducted 
experiments for each exposure time.  
 
3.4 Standard and enzyme-modified comet assays 
In the standard comet assay, CYN (0-2.5 µg/mL) did not induce DNA breaks in Caco-2 
cells at any concentrations tested after 24 and 48 h of exposure (Fig. 1a). For cells treated with 
100 µM of H202, a significant (p<0.01) increase in DNA breaks was observed after both times of 
exposure.  
CYN did not induce oxidation of pyrimidines and purines as revealed the results 
obtained after application of Endo III or FPG enzymes, respectively (Fig. 1b). Both positive 
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controls (H202 and Ro-19-8022 plus 5 min of 500 W visible light) showed significant increases of 
% tail DNA (p<0.01) under the conditions tested. 
 
4. Discussion 
 The fact that EFSA requires data on the toxicity profile of cyanotoxins for their correct 
risk assessment (Testai et al., 2016), makes the study of CYN genotoxicity a topic worth of 
research. In this sense, a thorough genotoxicity evaluation of CYN by in vitro assays has been 
performed including the Ames test, MN, MLA and the comet assays.  
 
With regard to the Ames test, the present study shows that CYN was non-mutagenic 
with and without S9 fraction using five S. typhimurium strains (TA97A, TA98, TA100, TA102 and 
TA104). Among the strains used, TA102 and TA104 were the only responsive ones although the 
MI were ≤2. This could be related to the already known CYN capacity to induce oxidative 
stress, because as stated by Mortelsman and Zeiger (2000), strains TA102 and TA104 may be 
used if it is suspected that the chemical may induce oxidative damage, or be a DNA cross-
linking agent. TA102, the most responsive strain in this case, is especially sensitive for 
detecting DNA cross-linking damage because it has an intact (wild-type) DNA excision repair 
mechanism which is required for the repair of that kind of damage. 
Similarly to our results, Sieroslawska (2013) reported that CYN exhibit no mutagenic 
activity in the Ames microplate format mutagenicity assay for the strains used, S. typhimurium 
TA98, TA100, TA1535, TA1537 and Escherichia coli WP2 uvrA and WP2 [pKM101] with or 
without metabolic activation with S9 fraction. In the case of CYN, no more data are available so 
far about its mutagenic potential by this test.   
No single mutagenicity test can detect all types of potential human mutations with 
100% accuracy or prediction (Pathak et al., 2017). Moreover, Kirkland et al. (2011) concluded 
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that data from Ames and in vitro MN tests allow the detection of all relevant toxicants causing 
in vivo carcinogenicity. In the present work, the MN test results indicated no significant 
variations in the frequency of MN in binucleated cells in absence of exogenous metabolic 
activation S9 fraction in comparison to the negative control group. However, the increment of 
BNMN frequency observed in the presence of S9 fraction indicated that potential genotoxic 
damage could be due to its metabolites. It has been reported that metabolic transformation of 
CYN is crucial for toxin-induced toxicity, and particularly for its genotoxicity (Fessard and 
Bernard, 2003; Bain et al., 2008). Similarly to our results, no significant difference was 
observed in the frequency of MN in the undifferentiated human hepatoma cell line HepaRG 
exposed to CYN (Bazin et al., 2010). However, in differentiated HepaRG cells (with CYN-
metabolizing capability as indicated by the authors) the frequencies of BNMN increased from 
0.04 µg/mL to 0.3 µg/mL CYN. This different genotoxic response between undifferentiated and 
differentiated HepaRG evidenced that metabolism of CYN was required. The same authors 
observed that there was a significant increase in the frequency of BNMN in undifferentiated 
and differentiated Caco-2 cells (Bazin et al., 2010). There are other authors that have also 
reported CYN genotoxicity by the MN assay. Thus, Humpage et al. (2000) demonstrated that 
CYN produced cytogenetic damage in vitro as it clearly induced whole chromosome and 
chromatics loss in the range 1-10 µg/mL after 24h exposure in human WIL2-NS lymphoblastoid 
cell line. Similarly, CYN induced MN in HepG2 cells after 24 h of exposure (Straser et al., 2011; 
Hercog et al., 2017) and in HPBLs after 4 and 24 h (Zegura et al., 2011b). Moreover, CYN 
induced genotoxic effects in fish CLC cell line using the MN assay with the highest toxin 
concentration used (1µg/mL) (Sieroslawka and Rymuszka, 2015). Nevertheless, no data on CYN 
metabolite identification were available in WIL2-NS, HepG2, HPBLs and CLC cell lines.  
Nowadays, the process underlying the metabolic activation of CYN is not yet 
elucidated (Kittler et al., 2014). In the present work, S9 fraction was used, which is a co-factor-
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supplemented post-mitochondrial fraction prepared from the livers of rodents treated with a 
combination of phenobarbital and β-naphthoflavone, according to OECD 487. These enzymatic 
inductors increase the levels of several CYP enzymes, in particular the CYP1A subfamily of 
enzymes (CYP1A1 and CYP1A2) (Ku et al., 2007). Our results indicated that this exogenous 
metabolising system, which induces mixed-function oxidases, is involved in the genotoxic 
effects of CYN in L5178Y Tk+/− cells. In this sense, Straser et al. (2011) and Hercog et al. (2017) 
showed that exposure of HepG2 cells to CYN induced the up-regulation of CYP genes CYP1A1 
and CYP1A2 providing further evidence that these enzymes are involved in the metabolic 
activation of CYN. Similar explanations were also proposed by Humpage et al. (2005) who 
observed that CYP450-derived metabolites were responsible for genotoxicity induced by CYN-
exposed hepatocytes.  
Apart from the in vitro mammalian cell MN test, there is also a different assay 
commonly used to investigate chromosome aberrations, the in vitro mammalian chromosomal 
aberration test (EFSA, 2011). Lankoff et al. (2007) observed no significant influence on the 
frequency of asymmetrical structural chromosome aberrations in CHO-K1 cells exposed to CYN 
with and without S9 fraction after performing this test.  
 
In the present study, there is a lack of agreement between the negative results 
obtained in bacterial cells (Ames test) in presence of external metabolic activation and the 
positive results obtained in the in vitro mammalian cell MN test with S9 fraction. This could be 
explained by differences in the concentrations used, the different experimental models and 
the duration of the exposure in each assay (Kirkland et al., 2014). In any case, both assays 




Based on our findings and following the criteria of EFSA (2011), as the Ames test and 
the MN assay have shown different results, it may be appropriate to conduct further testing in 
vitro. In this regard, two additional genotoxicity tests have been performed, the MLA and the 
comet assay. In relation to the MLA, this is the first time that it has been applied to study CYN 
genotoxicity. This test has the potential to detect mutagenic events at the thymidine kinase 
(tk) locus of L5178Y mouse lymphoma tk (+/-) cells by measuring resistance to the lethal 
nucleoside analogue TFT (Lloyd and Kidd, 2012). This test, along with the Ames test, is 
considered by EFSA (2011) one of the most commonly used in vitro methods to investigate 
gene (point) mutations. Moreover, this test can detect also other genetic events leading to the 
inactivation or loss of heterozygosity of the tk gene, such as large deletions or mitotic 
recombination (EFSA, 2011). The negative results obtained with absence and presence of S9 
fraction agree with those of the another mutagenicity test performed, the Ames test.  
 
The standard comet assay was performed on Caco-2 cells, as human intestine is a 
target tissue for xenobiotics after oral exposure. It is based on the ability of a SB to relax 
supercoiling in a loop of DNA, thus allowing the DNA to extend to the anode during 
electrophoresis forming a comet-like image in which the relative intensity of the comet tail 
reflects the break frequency (Azqueta and Collins, 2016). This assay is the most frequently 
used to evaluate the genotoxicity of CYN. In this work, CYN did not induce DNA SBs after 24 or 
48 h at any of the assayed concentrations in Caco-2 cells. Similar results were obtained by 
Fessard and Bernard (2003) in CHO-K1 cells exposed to CYN (0.5 and 1 µg/mL) for 24h, by 
Liebel et al. (2011) in Prochilodus lineatus hepatocytes exposed for 72 h to 0.1, 1 and 10 
µg/mL, and by Silva et al. (2017) in Hoplias malabaricus hepatocytes exposed for 72h to 0.1-
100 µg/L. Also, CYN after 4 h exposure did not induce % DNA in tail in the metabolically 
competent human hepatoma cell line HepG2 (Straser et al., 2011; 2013b). Nevertheless, after 
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prolonged exposure (12, 24, 18 and 72 h), CYN (0.01- 0.5 µg/mL) induced formation of DNA 
double SBs in this cell line (Straser et al., 2011; 2013b,c). This was also confirmed by Hercog et 
al. (2017) in the same cellular type as no SBs were observed at 4h, but positive results were 
obtained after 24h CYN exposure in a similar concentration range. Moreover, additional 
reports evidencing the genotoxicity of CYN by the comet assay are available in the scientific 
literature. Thus, a significant concentration-dependent increase in comet tail moment of nuclei 
from mouse primary hepatocytes treated with 0.05 to 0.5 µM CYN for 18 h was observed by 
Humpage et al. (2005). Similarly, carp leukocytes exposed to 0.5 µg/mL CYN for 18 h showed a 
high level of DNA damage (Sieroslawska and Rymuszka, 2013). Zegura et al. (2011b) showed 
that in HPBLs non-toxic concentrations of CYN induced a significant increase of DNA SBs after 4 
and 24 h of exposure. One more time, the variability in experimental models, exposure times 
and concentrations used could explain the differences observed. 
  
As it has been shown above, CYN genotoxicity by the comet assay has been widely 
investigated. However, the modified version of the comet assay in order to elucidate the 
potential contribution of oxidative stress on CYN genotoxicity has been scarcely applied. This is 
noteworthy taking into account that it is well documented that CYN produces changes in some 
oxidative stress biomarkers such as ROS content in vitro (Humpage et al., 2005; Liebel et al., 
2011; Gutierrez-Praena et al., 2011a; 2012a,b; López-Alonso et al., 2013; Straser et al., 2013b; 
Sieroskawska and Rymuszka, 2015). Oxidative stress and ROS formation could be the cause of 
CYN genotoxicity. The importance of DNA oxidations is emphasized by their mutagenic 
potential, although they have multiple additional roles in aging and cancer, including, e.g., 
mitochondrial function, microsatellite instability and telomere shortening (Evans et al., 2004). 
The use of lesion-specific enzymes has added a higher value to the standard comet assay, and 
FPG in particular has been used in many investigations of oxidative damage to DNA (Azqueta 
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and Collins, 2013). In the present study, the alkaline comet assay in combination with Endo III 
and FPG were used to detect oxidized pyrimidines and purine bases, respectively (Collins and 
Azqueta, 2012). The enzymes induce additional breaks at the sites of oxidized bases and 
increase the DNA in the tail of the comets (Glei et al., 2016). Our results show that CYN did not 
show DNA-oxidative effects when Endo III and FPG were used. With this assay, it was 
demonstrated that ROS are not mediators of CYN genotoxicity at the experimental conditions 
employed. There is only an additional study by Straser et al. (2013b) that applied the modified 
version of the comet assay to investigate the genotoxicity of up to 0.5 µg/mL CYN in HepG2 
cells, but only FPG was used. The authors concluded that the DNA damage caused by CYN was 
unlikely to be due to oxidative stress, although increased ROS levels were detected. This 
observation was in accordance with the results obtained in vitro by Humpage et al. (2005) as 
they observed no changes in malondialdehyde (a biomarker of lipid peroxidation) in CYN-
exposed mouse hepatocytes. In vivo, in liver of fish, DNA oxidation was not evidenced 
(Gutiérrez-Praena et al., 2011b). These negative results could be explained as some DNA 
oxidation products are repaired by enzymes of the base excision repair (BER) pathway (David 
et al., 2007; Loft and Moller, 2006) maintaining the DNA its original structure. However, other 
works reported that there is a direct connection between CYN-mediated induction of oxidative 
stress and DNA damage, such as Sieroslawska and Rymuszka (2015) in a carp leucocyte cell line 
after 24 h treatment, or Guzmán-Guillén et al. (2013) in liver and kidney of tilapia fish exposed 
to 100 µg CYN/L for 7 or 14 days. 
 
To sum up, regarding the four different genotoxicity/mutagenicity assays performed, 
only positive results were obtained in the MN test with the metabolic fraction S9. This implies 
that CYN metabolites can induce chromosomal damage. In this regard, it has been suggested 
that the parent compound and the possibly formed metabolites could exert toxicity with a 
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different mechanism, also depending on CYN concentrations (Buratti et al., 2017). 
Unfortunately, CYN metabolites have not been identified so far. The discrepancies observed 
among our results and those reported by the scientific literature could be due to different 
reasons such as 1) the variety of experimental models, 2) differences in uptake; 3) the range of 
concentrations assayed; 4) differences in the metabolic status of the cell lines (Huguet et al., 
2014) including CYP expression and presence of tissue-specific CYP isoforms (Bazin et al., 
2010); 5) exposure times; 6) DNA repair processes and 7) the use of no standard assay 
protocols.  
 
Overall, our results suggest that CYN could be a pro-genotoxic compound in 
mammalian in vitro models as positive results were only obtained when the metabolic fraction 
S9 was used in L5178Y Tk+/− cells. Moreover, oxidative stress seems to be not directly related 
to genotoxicity as the modified version of the comet assay provided negative results at the 
conditions tested. These data will contribute to a more realistic risk assessment of this 
prevalent cyanotoxin in waters and food.  
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Tables and figure captions: 
Table 1. Results of the Ames test conducted with CYN. Milli Q water was used as negative 
control and DMSO (10 µL) as solvent for positive controls. Data are given as mean ± SD 
revertants/plate of 3 independent experiments and mutagenicity index (MI). Positive controls 
without S9 fraction for TA 97A/TA98/TA102/TA104: 2-Nitrofluorene (0.1µg/plate) and for 
TA100: NaN3 (1 µg/plate). Positive control for all strains with S9 fraction: 2-Aminofluorene (20 
µg/plate). ** p<0.01 significantly different from negative controls.  
 
Table 2. Percentage of binucleated cells with micronuclei (BNMN) and cytokinesis-block 
proliferation index (CBPI) in cultured mouse lymphoma cells L5178YTk +/- exposed to CYN. The 
genotoxicity assay was performed in absence and presence of the metabolic fraction S9. The 
values are expressed as mean  SD The significance levels observed are * p<0.05, ** p<0.01, 
*** p<0.001 in comparison to control group values (negative control= medium). 
 
Table 3. Toxicity and mutagenicity of CYN in L5178YTk +/- cells after 4h without S9 fraction (a) 
4h with S9 fraction (b) and 24h without S9 fraction (c) by the MLA.  *** p<0.001 significantly 
different from negative control (medium). Positive controls: methylmethanesulfonate, MMS 
10 µg/mL without S9 fraction and cyclophosphamide, CP 3 µg/mL with S9 fraction. a Total 
mutant frequency divided into small/large (S/L) colony mutant frequencies. The induced 
mutant frequency (IMF) was determined according to the formula IMF = MF-SMF, where MF is 
the test culture mutant frequency and SMF is the spontaneous mutant frequency. 
 
Figure 1. Effect of CYN on DNA strand-breaks (SBs) and net Endo-FPG-sensitive sites of Caco-2 
cells exposed for 24 and 48 h using the standard alkaline (a) and modified-comet assay (b). The 
levels of DNA SBs, oxidized pyrimidines and oxidized purines are expressed as % tail DNA. All 
30 
 
values are expressed as mean ± SD of three independent experiments. The significance levels 
observed are ** p<0.01 in comparison to negative control group values (medium). Positive 
controls: 100 µM H2O2 for the standard comet assay and Endo III-sensitive sites, and 2 µM of 
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BNMN (%) ± SD CBPI ± SD 
Negative 
control 











24 0.08  0.4±0.2 1.8±0.0  4 0.13 0.8±0.3  1.8±0.1 
24 0.16  0.1±0.2  1.6±0.2 4 0.25 1.3±0.2* 1.8±0.0 
24 0.33 0.4±0.6 1.8±0.1 4 0.5 1.5±0.1** 1.8±0.1 
24 0.67 0.2±0.3 1.6±0.2 4 1.0  2.1±0.4** 1.9±0.1 
24 1.35 0.4±0.2 1.4±0.1** 4 2.0  2.0±0.9** 1.8±0.1 
Table 2
Table 3a.  In absence of S9 (4h) 
 
Table 3b.  In presence of S9 (4h)  
Concentration 
(µg/mL) 
Relative total growth 
Percent plating 
efficiency 

























0 100 100 120 113 69,1 94,3 41/28 61/34 - - 
0.042 95 103 143 116 118 146 96/22 119/27 49 52 
0.084 102 110 135 100 102 137 82/20 110/27 33 43 
0.168 86 109 127 111 113 130 97/16 111/19 44 36 
0.338 92 108 113 102 146 162 119/27 132/30 77 68 
0.675 75 82 124 67 127 170 91/36 121/49 58 76 
MMS (10 µg/mL) 58 63 88 35 1880*** 1080*** 1198/682 688/392 1810 986 
Concentration 
(µg/mL) 
Relative total growth 
Percent plating 
efficiency 

























0 100 100 76 118 132 107 63/69 55/45 - - 
0.042 90 97 80 88 145 127 86/84 67/60 13 20 
0.084 71 95 88 87 160 128 80/79 63/66 27 21 
0.168 68 61 84 90 189 156 163/98 122/34 56 49 
0.338 41 55 106 140 177 190 106/71 67/30 44 83 
0.675 37 29 81 76 154 161 88/67 93/68 22 54 
CP (3 µg/mL) 52 69 96 71 1020*** 1555*** 519/483 896/654 888 1448 
Table 3




Relative total growth 
Percent plating 
efficiency 

























0 100 100 93 76 115 171 95/20 136/40 - - 
0.042 65 97 100 74 207 124 150/57 70/54 91 -48 
0.084 62 96 111 67 194 154 128/66 90/64 79 -17 
0.168 58 91 127 88 121 148 56/65 88/60 6 -24 
0.338 64 61 113 56 162 181 93/69 129/135 47 9 
0.675 30 26 58 65 141 231 78/63 180/51 26 59 










































Net FPG-sensitive sites Net Endo-sensitive sites 
** 
** 
Figure 1
